<div class="table-container">
  <table class="autoantibody-table">
    <thead>
      <tr>
        <th colspan="6" style="text-align: center; background-color: #d0e5f5;">
          <strong>Heme-Onc Gene Mutations Summary</strong>
        </th>
      </tr>
      <tr>
        <th style="background-color: #f7f9fa;">Disease</th>
        <th style="background-color: #f7f9fa;">Gene / Mutation</th>
        <th style="background-color: #f7f9fa;">Cytogenetics</th>
        <th style="background-color: #f7f9fa;">Mechanism</th>
        <th style="background-color: #f7f9fa;">Category</th>
        <th style="background-color: #f7f9fa;">Lineage</th>
      </tr>
    </thead>
    <tbody>
<tr><td>Chronic Myeloid Leukemia (CML)</td><td>BCR-ABL fusion</td><td>t(9;22), Philadelphia chromosome</td><td>Oncogene activation</td><td>Oncogene</td><td>Myeloid</td></tr>
<tr><td>Acute Promyelocytic Leukemia (APL)</td><td>PML-RARA fusion</td><td>t(15;17)</td><td>Oncogene activation</td><td>Oncogene</td><td>Myeloid</td></tr>
<tr><td>Burkitt Lymphoma</td><td>MYC translocation</td><td>t(8;14)</td><td>Oncogene activation</td><td>Oncogene</td><td>Lymphoid</td></tr>
<tr><td>Mantle Cell Lymphoma</td><td>Cyclin D1 (CCND1) translocation</td><td>t(11;14)</td><td>Oncogene activation</td><td>Oncogene</td><td>Lymphoid</td></tr>
<tr><td>Follicular Lymphoma</td><td>BCL2 translocation</td><td>t(14;18)</td><td>Apoptosis inhibition</td><td>Non-Oncogenic</td><td>Lymphoid</td></tr>
<tr><td>Diffuse Large B-Cell Lymphoma</td><td>BCL6 mutations</td><td>various</td><td>Oncogene activation</td><td>Oncogene</td><td>Lymphoid</td></tr>
<tr><td>Hairy Cell Leukemia</td><td>BRAF V600E mutation</td><td>point mutation</td><td>MAPK pathway activation</td><td>Non-Oncogenic</td><td>Other</td></tr>
<tr><td>Acute Lymphoblastic Leukemia (ALL)</td><td>TEL-AML1, BCR-ABL</td><td>various</td><td>Fusion oncogenes</td><td>Oncogene</td><td>Lymphoid</td></tr>
<tr><td>T-ALL</td><td>NOTCH1 gain-of-function</td><td>point mutation</td><td>T-cell proliferation</td><td>Non-Oncogenic</td><td>Lymphoid</td></tr>
<tr><td>Chronic Lymphocytic Leukemia (CLL)</td><td>Deletion 13q14</td><td>del(13q)</td><td>Tumor suppressor loss</td><td>Tumor Suppressor</td><td>Lymphoid</td></tr>
<tr><td>Multiple Myeloma</td><td>Deletion 17p (TP53)</td><td>del(17p)</td><td>Tumor suppressor loss</td><td>Tumor Suppressor</td><td>Other</td></tr>
<tr><td>Myelodysplastic Syndromes (MDS)</td><td>Deletion 5q</td><td>del(5q)</td><td>Tumor suppressor loss</td><td>Tumor Suppressor</td><td>Myeloid</td></tr>
<tr><td>Polycythemia Vera</td><td>JAK2 V617F</td><td>point mutation</td><td>Tyrosine kinase activation</td><td>Non-Oncogenic</td><td>Myeloid</td></tr>
<tr><td>Essential Thrombocythemia</td><td>JAK2, CALR, MPL</td><td>point mutations</td><td>Signal transduction</td><td>Non-Oncogenic</td><td>Myeloid</td></tr>
<tr><td>Primary Myelofibrosis</td><td><b>JAK2</b></JAK2>, CALR, MPL</td><td>point mutations</td><td>Signal transduction</td><td>Non-Oncogenic</td><td>Myeloid</td></tr>
<tr><td>Hemochromatosis</td><td>HFE mutation</td><td>Chromosome 6p21.3</td><td>Iron overload disorder (non-oncogenic)</td><td>Non-Oncogenic</td><td>Other</td></tr>
<tr><td>Sickle Cell Disease</td><td>HBB gene mutation (Glu6Val)</td><td>Chromosome 11p15.5</td><td>Structural hemoglobinopathy</td><td>Non-Oncogenic</td><td>Other</td></tr>
<tr><td>Thalassemia (alpha)</td><td>HBA1, HBA2 deletions</td><td>Chromosome 16</td><td>Reduced alpha-globin synthesis</td><td>Non-Oncogenic</td><td>Other</td></tr>
<tr><td>Thalassemia (beta)</td><td>HBB point mutations</td><td>Chromosome 11</td><td>Reduced beta-globin synthesis</td><td>Non-Oncogenic</td><td>Other</td></tr>
<tr><td>G6PD Deficiency</td><td>G6PD mutation</td><td>Xq28</td><td>Enzymopathy – hemolytic anemia</td><td>Non-Oncogenic</td><td>Other</td></tr>
<tr><td>Hereditary Spherocytosis</td><td>ANK1, SPTB, SPTA1, EPB42</td><td>Various</td><td>Membrane defect (non-oncogenic)</td><td>Non-Oncogenic</td><td>Other</td></tr>
<tr><td>Fanconi Anemia</td><td>FANC genes</td><td>Various</td><td>DNA repair defect – pancytopenia, ↑ cancer risk</td><td>Non-Oncogenic</td><td>Other</td></tr>
<tr><td>Paroxysmal Nocturnal Hemoglobinuria</td><td>PIGA mutation</td><td>X chromosome</td><td>Complement regulation defect</td><td>Non-Oncogenic</td><td>Other</td></tr>
    </tbody>
  </table>
